Press Releases

Arch Therapeutics Completes Enrollment and Initiates Dosing in Skin Sensitization Study
Arch Therapeutics to Provide Corporate Update at the 8th LD Micro Invitational on Monday, June 4, 2018
Arch Therapeutics Provides Update on Study Initiation and 510(k)
Arch Therapeutics Provides Update on 510(k)
Arch Therapeutics to Provide Corporate Update at the 30th Annual Roth Conference on March 12, 2018
Dermatologic Surgery Publishes Clinical Data on Arch Therapeutics’ AC5™ in a Topical Application
Arch Therapeutics to Provide Corporate Update at The 10th Annual Biotech Showcase™ 2018 Conference on January 8th, 2018
Arch Therapeutics Withdraws 510(k) with Plans to Resubmit After Further Discussions with FDA
Arch Therapeutics to Provide Corporate Update at the 10th Annual LD Micro Main Event In Los Angeles December 5-7, 2017
Arch Therapeutics to Provide Corporate Updates at Upcoming Industry and Investment Conferences
RSS
Show All